Literature DB >> 12974632

The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies.

Yair Porat1, Sofiya Kolusheva, Raz Jelinek, Ehud Gazit.   

Abstract

The formation of amyloid fibrils by the human islet amyloid polypeptide is associated with type II diabetes. While it was previously suggested that the formed fibrils are toxic to pancreatic beta-cells due to membrane permeation activity, more recent studies suggested that protofibrillar assemblies have significantly higher potency in permeating lipid bilayers. Here, we specifically studied the membrane interaction activity of soluble and insoluble islet amyloid polypeptide assemblies at high temporal resolution. A colorimetric analysis using lipid/polydiacetylene (PDA) biomimetic vesicles clearly demonstrated the transient formation of soluble assemblies that strongly interact with the lipid vesicles. A peak in the level of membrane binding of the soluble fraction, as reflected by the colorimetric assay, was observed after incubation for approximately 1 h, followed by a decrease in the level of membrane interaction of the assemblies. The transient nature of the membrane-active assemblies was independently confirmed by a fluorescence quenching assay. Ultrastructural analysis using transmission electron microscopy provided morphological evidence of prefibrillar assemblies, supported the transient existence of membrane interacting soluble species, and facilitated observation of the non-membrane-active filaments in the solution. Taken together, our results provide experimental evidence for the formation of transient soluble prefibrillar assemblies which are highly membrane-active. The implications of these observations are discussed in light of designed fibrillization inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974632     DOI: 10.1021/bi034889i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  46 in total

1.  Reverse engineering an amyloid aggregation pathway with dimensional analysis and scaling.

Authors:  J Bailey; K J Potter; C B Verchere; L Edelstein-Keshet; D Coombs
Journal:  Phys Biol       Date:  2011-11-25       Impact factor: 2.583

2.  Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.

Authors:  Jeffrey R Brender; Edgar L Lee; Kevin Hartman; Pamela T Wong; Ayyalusamy Ramamoorthy; Duncan G Steel; Ari Gafni
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

Review 3.  Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

Authors:  F Rahimi; A Shanmugam; G Bitan
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 4.  Self assembly of short aromatic peptides into amyloid fibrils and related nanostructures.

Authors:  Ehud Gazit
Journal:  Prion       Date:  2007-01-02       Impact factor: 3.931

5.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Authors:  Maarten F M Engel; Lucie Khemtémourian; Cécile C Kleijer; Hans J D Meeldijk; Jet Jacobs; Arie J Verkleij; Ben de Kruijff; J Antoinette Killian; Jo W M Höppener
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-11       Impact factor: 11.205

Review 6.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

Review 7.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

8.  Islet amyloid polypeptide toxicity and membrane interactions.

Authors:  Ping Cao; Andisheh Abedini; Hui Wang; Ling-Hsien Tu; Xiaoxue Zhang; Ann Marie Schmidt; Daniel P Raleigh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  Influence of methionine-ruthenium complex on the fibril formation of human islet amyloid polypeptide.

Authors:  Gehui Gong; Jufei Xu; Xiangyi Huang; Weihong Du
Journal:  J Biol Inorg Chem       Date:  2019-01-30       Impact factor: 3.358

10.  A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity.

Authors:  Jeffrey R Brender; Kevin Hartman; Kendra R Reid; Robert T Kennedy; Ayyalusamy Ramamoorthy
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.